Cardiac drug could cut breast cancer mortality: Aussie study
Women taking carvedilol at diagnosis have a better chance of survival, Melbourne research shows
The beta-blocker carvedilol could reduce the progression of breast cancer, increasing the odds of surviving the cancer, according to a study by Melbourne’s Monash University.
In collaboration with a team from the Cancer Registry of Norway, the Monash researchers investigated the effects of carvedilol in more than 4000 breast cancer patients.
